Skip to main content
. 2020 Oct 13;13(3):1239–1243. doi: 10.1159/000510096

Fig. 1.

Fig. 1

Serial abdominal contrast CT images of the patient. aAt the time of diagnosis − June 2014. bOn gemcitabine and Abraxane − October 2015. cOn dabrafenib and trametinib with response − September 2019. dOn dabrafenib and trametinib with mixed response − March 2020. eSegment 3 lesion in the liver of 0.9 mm − September 2019. fSingle lesion showing an increase in size to 2.2 cm in segment 3 of the liver − March 2020.